 Lindsey Westbrook
Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Granuloma, Foreign-Body | 1 | 2020 | 10 | 0.710 |
Why?
| | Poloxamer | 1 | 2020 | 12 | 0.710 |
Why?
| | Endoscopy | 1 | 2020 | 246 | 0.590 |
Why?
| | Adenocarcinoma | 4 | 2022 | 795 | 0.470 |
Why?
| | Neoplasm Invasiveness | 2 | 2022 | 442 | 0.220 |
Why?
| | Doxycycline | 1 | 2022 | 55 | 0.200 |
Why?
| | Criminals | 1 | 2022 | 29 | 0.200 |
Why?
| | Smooth Muscle Tumor | 1 | 2020 | 6 | 0.180 |
Why?
| | Genes, APC | 1 | 2020 | 13 | 0.180 |
Why?
| | Schwann Cells | 1 | 2020 | 27 | 0.180 |
Why?
| | Adenomatous Polyps | 1 | 2020 | 8 | 0.170 |
Why?
| | Hamartoma | 1 | 2020 | 21 | 0.170 |
Why?
| | Esophagogastric Junction | 1 | 2020 | 42 | 0.170 |
Why?
| | Colonic Neoplasms | 1 | 2022 | 222 | 0.170 |
Why?
| | Esophagus | 1 | 2021 | 226 | 0.170 |
Why?
| | Stomach Neoplasms | 1 | 2020 | 65 | 0.170 |
Why?
| | Mucous Membrane | 1 | 2020 | 108 | 0.170 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2020 | 60 | 0.170 |
Why?
| | Goblet Cells | 1 | 2019 | 16 | 0.160 |
Why?
| | Neoplasms, Complex and Mixed | 1 | 2019 | 7 | 0.160 |
Why?
| | Lymphoproliferative Disorders | 1 | 2019 | 46 | 0.160 |
Why?
| | Appendiceal Neoplasms | 1 | 2019 | 14 | 0.160 |
Why?
| | Carcinoid Tumor | 1 | 2019 | 25 | 0.160 |
Why?
| | Staining and Labeling | 1 | 2019 | 135 | 0.160 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2019 | 72 | 0.160 |
Why?
| | Esophageal Neoplasms | 1 | 2021 | 273 | 0.150 |
Why?
| | Gastrointestinal Diseases | 1 | 2019 | 182 | 0.150 |
Why?
| | Pyrimidines | 1 | 2018 | 376 | 0.130 |
Why?
| | Pyrazoles | 1 | 2018 | 362 | 0.130 |
Why?
| | Colorectal Neoplasms | 2 | 2020 | 617 | 0.130 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 698 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 788 | 0.110 |
Why?
| | Observer Variation | 2 | 2022 | 298 | 0.090 |
Why?
| | Middle Aged | 4 | 2020 | 26831 | 0.080 |
Why?
| | Aged | 3 | 2020 | 19122 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 1879 | 0.070 |
Why?
| | Humans | 11 | 2022 | 115052 | 0.070 |
Why?
| | Diagnosis, Differential | 2 | 2020 | 1355 | 0.060 |
Why?
| | Female | 6 | 2020 | 59619 | 0.060 |
Why?
| | Male | 4 | 2020 | 55737 | 0.050 |
Why?
| | Pathologists | 1 | 2022 | 15 | 0.050 |
Why?
| | Esophagectomy | 1 | 2021 | 111 | 0.050 |
Why?
| | S100 Proteins | 1 | 2020 | 38 | 0.040 |
Why?
| | Gastrointestinal Tract | 1 | 2022 | 169 | 0.040 |
Why?
| | Incidental Findings | 1 | 2020 | 76 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 337 | 0.040 |
Why?
| | Melanins | 1 | 2019 | 17 | 0.040 |
Why?
| | Rectum | 1 | 2020 | 150 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2020 | 109 | 0.040 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2018 | 41 | 0.040 |
Why?
| | M Phase Cell Cycle Checkpoints | 1 | 2018 | 23 | 0.040 |
Why?
| | Reference Standards | 1 | 2019 | 159 | 0.040 |
Why?
| | Fluorescence | 1 | 2019 | 148 | 0.040 |
Why?
| | Colon | 1 | 2020 | 233 | 0.040 |
Why?
| | Neoplasm Grading | 1 | 2019 | 243 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2019 | 91 | 0.040 |
Why?
| | Genetic Testing | 1 | 2020 | 380 | 0.040 |
Why?
| | Mice, Nude | 1 | 2018 | 631 | 0.030 |
Why?
| | Angiogenesis Inhibitors | 1 | 2018 | 214 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2018 | 697 | 0.030 |
Why?
| | Cell Cycle | 1 | 2018 | 544 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1133 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1169 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1046 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1634 | 0.030 |
Why?
| | Adult | 3 | 2020 | 30658 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2389 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1045 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3335 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 2716 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1489 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2191 | 0.020 |
Why?
| | Liver | 1 | 2019 | 1681 | 0.020 |
Why?
| | Apoptosis | 1 | 2018 | 2366 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 3350 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 6357 | 0.020 |
Why?
| | Lung | 1 | 2019 | 3595 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 9123 | 0.020 |
Why?
| | Young Adult | 1 | 2019 | 10498 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2019 | 12548 | 0.010 |
Why?
| | Mice | 1 | 2018 | 14928 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 17866 | 0.010 |
Why?
| | Animals | 1 | 2018 | 31868 | 0.010 |
Why?
|
|
Westbrook's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|